Angiographic Analysis of Pattern of Late Luminal Loss in Sirolimus- and Paclitaxel-Eluting Stents

American Journal of Cardiology

Volumn 99, Issue 5, 2007, Pages 593-598

  Agostoni, Pierfrancesco ^a,b   Cosgrave, John ^b   Biondi Zoccai, Giuseppe G L ^a   Sangiorgi, Giuseppe M ^a,b   Ge, Lei ^b   Melzi, Gloria ^a   Corbett, Simon ^b   Airoldi, Flavio ^a   Montorfano, Matteo ^a   Chieffo, Alaide ^a   Michev, Iassen ^a   Carlino, Mauro ^a   Colombo, Antonio ^a,b  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; COHORT ANALYSIS; CORONARY STENT; DISEASE MARKER; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; LATE LUMINAL LOSS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTENOSIS;

AGED; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; ENDOTHELIUM, VASCULAR; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; SIROLIMUS; STENTS; TIME FACTORS; TUBULIN MODULATORS;

EID: 33847053214     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.09.104     Document Type: Article

References (17)

1. Cosgrave J., Agostoni P., Ge L., Iakovou I., Chieffo A., Biondi-Zoccai G.L., Sangiorgi G.M., Montorfano M., Michev I., Airoldi F., et al. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions. Am J Cardiol 96 (2005) 1663-1668
2. Lehmann K.G., Melkert R., and Serruys P.W. Contributions of frequency distribution analysis to the understanding of coronary restenosis. A reappraisal of the gaussian curve. Circulation 93 (1996) 1123-1132
3. Schomig A., Kastrati A., Elezi S., Schuhlen H., Dirschinger J., Dannegger F., Wilhelm M., and Ulm K. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. Circulation 96 (1997) 3880-3887
4. Van der Zwet P., and Reiber J. A new approach for the quantification of complex lesion morphology: the gradient field transform; basic principles and validation results. J Am Coll Cardiol 24 (1994) 216-224
5. Lansky A.J., Dangas G., Mehran R., Desai K.J., Mintz G.S., Wu H., Fahy M., Stone G.W., Waksman R., and Leon M.B. Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation. J Am Coll Cardiol 39 (2002) 274-280
6. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., Pichard A.D., Kent K.M., Stone G.W., and Leon M.B. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 100 (1999) 1872-1878
7. Cutlip D.E., Chauan M.S., Baim D.S., Ho K.K.L., Popma J.J., Carrozza J.P., Cohen D.J., and Kuntz R.E. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 40 (2002) 2082-2089
8. Lemos P.A., Mercado N., van Domburg R.T., Kuntz R.E., O'Neill W.W., and Serruys P.W. Comparison of late luminal loss response pattern after sirolimus-eluting stent implantation or conventional stenting. Circulation 110 (2004) 3199-3205
9. Ellis S.G., Popma J.J., Lasala J.M., Koglin J.J., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: analysis from the TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1193-1200
10. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falotico R., and RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
11. Sousa J.E., Costa M.A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M., Seixas A.C., Staico R., Mattos L.A., Sousa A.G., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195
12. Grube E., Silber S., Hauptmann K.E., Mueller R., Buellesfeld L., Gerckens U., and Russell M.E. TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. Circulation 107 (2003) 38-42
13. Mauri L., Orav E.J., O'Malley A.J., Moses J.W., Leon M.B., Holmes Jr. D.R., Teirstein P.S., Schofer J., Breithardt G., Cutlip D.E., et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 111 (2005) 321-327
14. Mauri L., Orav E.J., and Kuntz R.E. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111 (2005) 3435-3442
15. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
16. Agostoni P., Valgimigli M., Abbate A., Cosgrave J., Pilati M., and Biondi-Zoccai G. Is late luminal loss an accurate predictor of the clinical effectiveness of drug-eluting stents in the coronary arteries?. Am J Cardiol 97 (2006) 603-605
17. Agostoni P. Letter regarding article "Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison". Circulation 112 (2005) e358